Sunday share tips: Astrazeneca, Galliford Try, Grainger
5th Jul 2015 13:56
Buy shares in Astrazeneca said Questor in the Sunday Telegraph. The London-listed company is one of the foremost developers of cancer treatments in the world, especially in the exciting new field of immuno-oncology, which use the body's own immune system to recognise and destroy cancer cells. Analys
Read moreSunday share tips: Astrazeneca, Galliford Try, Grainger
5th Jul 2015 13:56
Buy shares in Astrazeneca said Questor in the Sunday Telegraph. The London-listed company is one of the foremost developers of cancer treatments in the world, especially in the exciting new field of immuno-oncology, which use the body's own immune system to recognise and destroy cancer cells. Analys
Read moreBroker tips: Serco, Smiths Group, Jimmy Choo, AstraZeneca
2nd Jul 2015 11:22
Serco's stock was extending gains on Wednesday after a well-received first-half trading update the day before, with Numis Securities providing a further boost by upgrading its recommendation from 'reduce' to 'hold'. Numis said Serco revelations that first-half trading had been a little better than e
Read moreBerenberg ups AstraZeneca to 'buy'; says oncology pipeline will drive growth
2nd Jul 2015 09:02
Berenberg upgraded AstraZeneca to 'buy' from 'hold' and raised the price target to 5,200p from 4,800p, saying that Oncology will drive future growth. Berenberg noted that AZN shares reached highs of 4,800p during last year's Pfizer approach. Since then, sentiment has weakened and the shares are not
Read moreFriday broker round-up
26th Jun 2015 10:11
ARM Holdings: Bernstein downgrades to underperform. GlaxoSmithKline: Liberum ups view to hold from sell. HSBC initiates coverage at buy with 1,700p target. AztraZeneca: HSBC initiates coverage at hold with 4,640p target. Qinetiq: UBS downgrades to sell from neutral. Meggitt: UBS raises view to ne
Read moreHSBC initiates coverage of European pharmaceuticals Astra, GSK, Hikma and Shire
26th Jun 2015 07:51
HSBC initiated coverage of the European pharmaceuticals, saying the re-rating over the last few years looks set to continue. Although some pharma companies, such as AstraZeneca, still face generic pressure for drugs that contribute significantly to their top and bottom lines, the majority are largel
Read moreBoris Johnson to suggest creating a "megafund" for biotech firms
25th Jun 2015 11:53
London mayor Boris Johnson on Thursday suggested that banks, investors and drug multinationals should condier creating a £10bn "megafund" to help biotech firms in the country to compete with US rivals. Johnson made the suggestion on the occasion of a conference in London that brought together the le
Read moreTuesday broker round-up
23rd Jun 2015 08:03
Acacia Mining: Morgan Stanley keeps at equalweight, raises target to 285p from 251p. BHP Billiton: Morgan Stanley stays at equalweight and lifts target to 1,250p from1,150p. Anglo American: Morgan Stanley reiterates underweight and lowers target to 850p from 920p. Antofagasta: Morgan Stanley still
Read moreLondon open: UK stocks drop to five-month low ahead of CPI data
16th Jun 2015 08:19
UK stocks dropped into the red for a third straight day on Tuesday on the back of ongoing concerns about Greece, a sell-off in China and caution ahead of inflation data. The FTSE 100 was trading 0.55% lower at 6,673.49 early on, after hitting a three-month closing low of 6,710.52 on Monday. The ind
Read moreThursday newspaper round-up: Iraq, UK house prices, Greece
11th Jun 2015 07:03
President Obama's election pledge not to drag the US into another war in Iraq was last night under increasing strain as he sent a further 450 soldiers to Anbar province to confront Isis. The move, which brings to about 3,550 the number of US troops in Iraq, underscores alarm at how the Iraqi army cr
Read moreWednesday newspaper round-up: FCA, AstraZeneca, Greece
3rd Jun 2015 07:29
The UK markets regulator has given his backing to asset managers fighting proposals that could see them labelled as potential threats to the financial system. Martin Wheatley, head of Britain's Financial Conduct Authority, said global regulators faced "big questions" that needed to be answered befor
Read moreFTSE 100 movers: Lloyds declines as state investment vehicle lowers stake, miners lower
1st Jun 2015 13:49
UK shares were trading lower on Monday afternoon, ahead of a raft of US economic data, as weakness in mining, oil and insurance stocks outweighed gains made in the real estate, travel and electronics sectors. As of 15:30 BST, the FTSE 100 was trading 0.23% lower at 6,988. Lloyds registered losses a
Read moreMonday broker round-up
1st Jun 2015 09:48
Lamprell: Citi reiterates neutral recommendation and raises target to 155p. British Land: JP Morgan ups target to 970p from 950p and stays at overweight. Derwent London: JP Morgan raises target to 3,900p from 3,800p but keeps at overweight. Great Portland Estates: JP Morgan lifts target to 920p fr
Read moreLondon open: Ahead of US data, stocks pare gains on Greek worries
1st Jun 2015 08:24
Stocks pared strong early gains ahead of a raft of US economic data scheduled for release in the afternoon amid continued worries over the situation in Greece. As of 08:56 the FTSE 100 was higher by 24.21 points to 7,008.64. The top flight index snapped higher at the start of the session following
Read moreAstraZeneca shares rise 2.5% after positive lung cancer drug update
1st Jun 2015 07:35
Shares in AstraZeneca rose 2.5% on Monday following positive takeaways from the annual meeting of the American Society of Clinical Oncology, during which the company presented preliminary data for one of its lung cancer drugs. The pharmaceuticals giant announced preliminary efficacy and safety data
Read more